These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 24670575)
1. Impact of chronic renal failure on anti-tuberculosis treatment outcomes. Baghaei P; Marjani M; Tabarsi P; Moniri A; Rashidfarrokhi F; Ahmadi F; Nassiri AA; Masjedi MR; Velayati AA; Cattamanchi A Int J Tuberc Lung Dis; 2014 Mar; 18(3):352-6. PubMed ID: 24670575 [TBL] [Abstract][Full Text] [Related]
2. Incidence, clinical and epidemiological risk factors, and outcome of drug-induced hepatitis due to antituberculous agents in new tuberculosis cases. Baghaei P; Tabarsi P; Chitsaz E; Saleh M; Marjani M; Shemirani S; Pooramiri MV; Kazempour M; Farnia P; Fahimi F; Mansouri D; Masjedi M Am J Ther; 2010; 17(1):17-22. PubMed ID: 19535968 [TBL] [Abstract][Full Text] [Related]
3. Incidence of antituberculosis-drug-induced hepatotoxicity and associated risk factors among tuberculosis patients in Dawro Zone, South Ethiopia: A cohort study. Wondwossen Abera ; Waqtola Cheneke ; Gemeda Abebe Int J Mycobacteriol; 2016 Mar; 5(1):14-20. PubMed ID: 26927985 [TBL] [Abstract][Full Text] [Related]
4. Hepatotoxicity of anti-tuberculosis chemotherapy in patients with liver cirrhosis. Shin HJ; Lee HS; Kim YI; Lim SC; Jung JP; Ko YC; Kwon YS Int J Tuberc Lung Dis; 2014 Mar; 18(3):347-51. PubMed ID: 24670574 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of risk factors for antituberculosis treatment induced hepatotoxicity. Singla R; Sharma SK; Mohan A; Makharia G; Sreenivas V; Jha B; Kumar S; Sarda P; Singh S Indian J Med Res; 2010 Jul; 132():81-6. PubMed ID: 20693595 [TBL] [Abstract][Full Text] [Related]
6. Weight loss during tuberculosis treatment is an important risk factor for drug-induced hepatotoxicity. Warmelink I; ten Hacken NH; van der Werf TS; van Altena R Br J Nutr; 2011 Feb; 105(3):400-8. PubMed ID: 20875187 [TBL] [Abstract][Full Text] [Related]
7. Mortality among tuberculosis patients in the Democratic Republic of Congo. Henegar C; Behets F; Vanden Driessche K; Tabala M; Bahati E; Bola V; Van Rie A Int J Tuberc Lung Dis; 2012 Sep; 16(9):1199-204. PubMed ID: 22871326 [TBL] [Abstract][Full Text] [Related]
8. [Drug-induced hepatotoxicity caused by anti-tuberculosis drugs in tuberculosis patients complicated with chronic hepatitis]. Kaneko Y; Nagayama N; Kawabe Y; Shimada M; Suzuki J; Kunogi M; Matsui Y; Kawashima M; Suzuki J; Ariga H; Oshima N; Masuda K; Matsui H; Nagai H; Tamura A; Akagawa S; Toyoda E; Machida K; Kurashima A; Yotsumoto H Kekkaku; 2008 Jan; 83(1):13-9. PubMed ID: 18283910 [TBL] [Abstract][Full Text] [Related]
9. Impact of renal function-based anti-tuberculosis drug dosage adjustment on efficacy and safety outcomes in pulmonary tuberculosis complicated with chronic kidney disease. Saito N; Yoshii Y; Kaneko Y; Nakashima A; Horikiri T; Saito Z; Watanabe S; Kinoshita A; Saito K; Kuwano K BMC Infect Dis; 2019 May; 19(1):374. PubMed ID: 31046706 [TBL] [Abstract][Full Text] [Related]
10. Burden of disease and risk factors for death among children treated for tuberculosis in Malawi. Flick RJ; Kim MH; Simon K; Munthali A; Hosseinipour MC; Rosenberg NE; Kazembe PN; Mpunga J; Ahmed S Int J Tuberc Lung Dis; 2016 Aug; 20(8):1046-54. PubMed ID: 27393538 [TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus infection increases hepatitis risk during anti-tuberculosis treatment. Chien JY; Huang RM; Wang JY; Ruan SY; Chien YJ; Yu CJ; Yang PC Int J Tuberc Lung Dis; 2010 May; 14(5):616-21. PubMed ID: 20392356 [TBL] [Abstract][Full Text] [Related]
12. Hyperglycemia during tuberculosis treatment increases morbidity and mortality in a contemporary cohort of HIV-infected patients in Rio de Janeiro, Brazil. Moreira J; Castro R; Lamas C; Ribeiro S; Grinsztejn B; Veloso VG Int J Infect Dis; 2018 Apr; 69():11-19. PubMed ID: 29253707 [TBL] [Abstract][Full Text] [Related]
13. Co-infection with hepatitis B virus among tuberculosis patients is associated with poor outcomes during anti-tuberculosis treatment. Chen L; Bao D; Gu L; Gu Y; Zhou L; Gao Z; Huang Y BMC Infect Dis; 2018 Jul; 18(1):295. PubMed ID: 29970037 [TBL] [Abstract][Full Text] [Related]
14. Treatment outcomes of tuberculosis patients in Brazilian prisons: a polytomous regression analysis. Ribeiro Macedo L; Reis-Santos B; Riley LW; Maciel EL Int J Tuberc Lung Dis; 2013 Nov; 17(11):1427-34. PubMed ID: 24125446 [TBL] [Abstract][Full Text] [Related]
15. Predictors and mortality associated with treatment default in pulmonary tuberculosis. Kliiman K; Altraja A Int J Tuberc Lung Dis; 2010 Apr; 14(4):454-63. PubMed ID: 20202304 [TBL] [Abstract][Full Text] [Related]
16. Prevalence and risk factors of anti-tuberculosis drug-induced hepatitis in Malaysia. Marzuki OA; Fauzi AR; Ayoub S; Kamarul Imran M Singapore Med J; 2008 Sep; 49(9):688-93. PubMed ID: 18830542 [TBL] [Abstract][Full Text] [Related]
17. The clinical impact of drug-induced hepatotoxicity on anti-tuberculosis therapy: a case control study. Song JH; Yoon SY; Park TY; Heo EY; Kim DK; Chung HS; Lee JK Respir Res; 2019 Dec; 20(1):283. PubMed ID: 31842883 [TBL] [Abstract][Full Text] [Related]
18. Clinical features and outcomes of tuberculosis in solid organ transplant recipients. Bodro M; Sabé N; Santín M; Cruzado JM; Lladó L; González-Costello J; Carratalà J Transplant Proc; 2012 Nov; 44(9):2686-9. PubMed ID: 23146494 [TBL] [Abstract][Full Text] [Related]
19. Can hepatitis B virus infection predict tuberculosis treatment liver toxicity? Development of a preliminary prediction rule. de Castro L; do Brasil PE; Monteiro TP; Rolla VC Int J Tuberc Lung Dis; 2010 Mar; 14(3):332-40. PubMed ID: 20132625 [TBL] [Abstract][Full Text] [Related]
20. Factors associated with mortality and default among patients with tuberculosis attending a teaching hospital clinic in Accra, Ghana. Burton NT; Forson A; Lurie MN; Kudzawu S; Kwarteng E; Kwara A Trans R Soc Trop Med Hyg; 2011 Dec; 105(12):675-82. PubMed ID: 21920570 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]